Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APGE

Apogee Therapeutics Inc

May 22 • 04:00PM ET

81.16

-1.27 -1.54 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: ARQT ANAB KYMR NRIX IMVT

| Held by: VTI XBI IWM TCAF VXF IWO IBB SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.33	Insider Own	24.46%	Shs Outstand	61.40M	Perf Week	0.02%
Market Cap	6.11B	Forward P/E	-	EPS next Y	-5.41	Insider Trans	-9.73%	Shs Float	56.91M	Perf Month	-8.08%
Enterprise Value	5.06B	PEG	-	EPS next Q	-1.08	Inst Own	92.79%	Short Float	16.67%	Perf Quarter	16.09%
Income	-274.62M	P/S	-	EPS this Y	-6.57%	Inst Trans	17.75%	Short Ratio	10.93	Perf Half Y	27.15%
Sales	0.00M	P/B	4.84	EPS next Y	-20.20%	ROA	-27.35%	Short Interest	9.49M	Perf YTD	7.53%
Book/sh	16.77	P/C	5.77	EPS next 5Y	-14.63%	ROE	-28.47%	52W High	95.32 -14.85%	Perf Year	101.09%
Cash/sh	14.07	P/FCF	-	EPS past 3/5Y	-75.11% -	ROIC	-21.78%	52W Low	34.34 136.34%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.58% 4.79%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-22.17%	Oper. Margin	-	ATR (14)	4.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	32.59	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.58	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	32.59	EPS Q/Q	-11.87%	SMA20	-1.76%	Beta	0.65	Target Price	119.69
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-1.07%	Rel Volume	0.39	Prev Close	82.43
Employees	261	LT Debt/Eq	0.00	Earnings	May 11 BMO	SMA200	24.68%	Avg Volume	868.15K	Price	81.16
IPO	Jul 14, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.97% -	Trades		Volume	338,435	Change	-1.54%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)